SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-01-005914
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND L PBVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.BVF, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A a2038569zsc13ga.txt SC 13G/A 23003
  Complete submission text file 0000912057-01-005914.txt   25294
Mailing Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-860-2500
EPIMMUNE INC (Subject) CIK: 0000822206 (see all company filings)

IRS No.: 330245076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46179 | Film No.: 1546224
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice